RecruitingNCT05008081
The CATALINA Study
An International Multi-centre Prospective Cohort Study in Patients Hospitalized for an Acute Exacerbation of COPD
Sponsor
Wim Janssens
Enrollment
1,000 participants
Start Date
Oct 25, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
The CATALINA study is a prospective cohort study embedded within CICERO (Collaboration In COPD ExaceRbatiOns, a European Respiratory Society supported Clinical Research Collaboration), designed to collect standardised, longitudinal clinical data and biological samples in 20 centres across Europe and beyond.
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- Age 18 years and older
- Established diagnosis of COPD by medical doctor (based on clinical history OR pulmonary function test with an FEV1/FVC \< 0.7)
- Current hospitalization with suspicion of an acute exacerbation of COPD (AECOPD)
- Inclusion within 48 hours post hospital admission
- Voluntary written informed consent of the participant or his/her representative obtained prior to any study procedure
Exclusion Criteria3
- Patients unwilling or unable to comply with study procedures
- Patients not requiring treatment with systemic corticosteroids, antibiotics or both as a minimum therapy for the index AECOPD
- Patients with a confirmed positive test result for COVID19, or those highly suspected based on clinical examination
Locations(18)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05008081